Aflac Incorporated (NYSE:AFL) Shares Sold by Ossiam

Ossiam trimmed its holdings in Aflac Incorporated (NYSE:AFL) by 54.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 100,921 shares of the financial services provider’s stock after selling 120,378 shares during the period. Ossiam’s holdings in Aflac were worth $10,439,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in Aflac in the fourth quarter valued at $3,401,000. Forum Financial Management LP boosted its holdings in shares of Aflac by 5.8% during the fourth quarter. Forum Financial Management LP now owns 8,831 shares of the financial services provider’s stock valued at $913,000 after acquiring an additional 487 shares during the period. GeoWealth Management LLC grew its position in Aflac by 32.0% in the 4th quarter. GeoWealth Management LLC now owns 7,390 shares of the financial services provider’s stock worth $764,000 after purchasing an additional 1,793 shares during the last quarter. Canada Pension Plan Investment Board grew its holdings in Aflac by 339.7% in the 4th quarter. Canada Pension Plan Investment Board now owns 303,454 shares of the financial services provider’s stock worth $31,389,000 after buying an additional 234,439 shares in the last quarter. Finally, Capital Square LLC acquired a new position in shares of Aflac during the fourth quarter valued at $205,000. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Aflac

In other news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $107.29, for a total value of $3,197,456.58. Following the transaction, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the transaction, the director now directly owns 25,393 shares of the company’s stock, valued at $2,733,048.59. This represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

AFL has been the subject of several research analyst reports. JPMorgan Chase & Co. upped their price objective on Aflac from $94.00 to $96.00 and gave the company a “neutral” rating in a report on Wednesday, April 2nd. Barclays cut their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a report on Friday, February 7th. Morgan Stanley lowered their price objective on shares of Aflac from $105.00 to $100.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 10th. Keefe, Bruyette & Woods cut their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. Finally, Piper Sandler lifted their price target on shares of Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 2nd. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Aflac currently has an average rating of “Hold” and a consensus target price of $103.93.

Aflac Price Performance

NYSE AFL opened at $107.35 on Friday. Aflac Incorporated has a fifty-two week low of $80.59 and a fifty-two week high of $115.50. The stock’s 50-day moving average is $106.72 and its two-hundred day moving average is $107.33. The firm has a market cap of $58.59 billion, a P/E ratio of 11.18, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.